Patents by Inventor Gary Dubin

Gary Dubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME
    Publication number: 20250381261
    Abstract: The present disclosure relates to vaccines and immunogenic compositions comprising an antigen from a Zika virus (e.g., wherein the antigen is an inactivated whole Zika virus), and their use in medical applications (such as methods of treatment).
    Type: Application
    Filed: February 9, 2022
    Publication date: December 18, 2025
    Inventors: Camilo Acosta, Htay Htay Han, John Boslego, Gary Dubin
  • Zika vaccines and immunogenic compositions, and methods of using the same
    Patent number: 12109260
    Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
    Type: Grant
    Filed: June 16, 2023
    Date of Patent: October 8, 2024
    Assignee: Takeda Vaccines, Inc.
    Inventors: Jill A Livengood, Hansi Dean, Htay Htay Han, Raman Rao, Jackie Marks, Gary Dubin, Laurence De Moerlooze, Hetal Patel, Sushma Kommareddy
  • ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME
    Publication number: 20240285747
    Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
    Type: Application
    Filed: September 5, 2023
    Publication date: August 29, 2024
    Inventors: Jill A. LIVENGOOD, HANSI DEAN, Htay Htay HAN, Raman RAO, Jackie MARKS, Gary DUBIN, Laurence DE MOERLOOZE, Hetal PATEL, Asae SHINTANI, Holli GIEBLER, James GIFFORD, Mark LYONS, Sushma KOMMAREDDY, Tatsuki SATOU
  • Zika vaccines and immunogenic compositions, and methods of using the same
    Patent number: 11975062
    Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: May 7, 2024
    Assignee: Takeda Vaccines, Inc.
    Inventors: Jill A. Livengood, Hansi Dean, Htay Htay Han, Raman Rao, Jackie Marks, Gary Dubin, Laurence De Moerlooze, Hetal Patel, Asae Shintani, Holli Giebler, James Gifford, Mark Lyons, Sushma Kommareddy, Tatsuki Satou
  • ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME
    Publication number: 20230414743
    Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
    Type: Application
    Filed: June 16, 2023
    Publication date: December 28, 2023
    Inventors: Jill A. LIVENGOOD, Hansi DEAN, Htay Htay HAN, Raman RAO, Jackie MARKS, Gary DUBIN, Laurence DE MOERLOOZE, Hetal PATEL, Sushma KOMMAREDDY
  • ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME
    Publication number: 20230398199
    Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.
    Type: Application
    Filed: November 30, 2018
    Publication date: December 14, 2023
    Inventors: Jill A. LIVENGOOD, Hansi DEAN, Htay Htay HAN, Raman RAO, Jackie MARKS, Gary DUBIN, Laurence DE MOERLOOZE, Hetal PATEL, Asae SHINTANI, Holli GIEBLER, James GIFFORD, Mark LYONS, Sushma KOMMAREDDY, Tatsuki SATOU
  • Zika vaccines and immunogenic compositions, and methods of using the same
    Patent number: 11730802
    Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: August 22, 2023
    Assignee: Takeda Vaccines, Inc.
    Inventors: Jill A Livengood, Hansi Dean, Htay Htay Han, Raman Rao, Jackie Marks, Gary Dubin, Laurence De Moerlooze, Hetal Patel, Sushma Kommareddy
  • ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME
    Publication number: 20210177958
    Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
    Type: Application
    Filed: November 5, 2018
    Publication date: June 17, 2021
    Inventors: Jill A LIVENGOOD, Hansi DEAN, Htay Htay HAN, Raman RAO, Jackie MARKS, Gary DUBIN, Laurence DE MOERLOOZE, Hetal PATEL, Sushma KOMMAREDDY
  • ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME
    Publication number: 20210106669
    Abstract: The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.
    Type: Application
    Filed: November 30, 2018
    Publication date: April 15, 2021
    Inventors: Jill A. LIVENGOOD, Hansi DEAN, Htay Htay HAN, Raman RAO, Jackie MARKS, Gary DUBIN, Laurence DE MOERLOOZE, Hetal PATEL
  • Vaccine
    Patent number: 7858098
    Abstract: This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: December 28, 2010
    Assignee: GlaxoSmithKline Biologicals, s.a.
    Inventors: Gary Dubin, Bruce Innis, Moncef Mohammed Slaoui, Martine Anne Cecile Wettendorff
  • Assay
    Publication number: 20070031828
    Abstract: A process for identification of type-specific polynucleotide sequences in a sample, the process comprising the steps of (1) contacting polynucleotides from the sample, or derived from the sample, with a plurality of type-specific probes in the context of a solid support, and detection of any type-specific hybridisation; and (2) contacting polynucleotides in the sample, or derived from the sample, with type-specific primers for those types capable of being detected by the hybridisation step in step 1, but not so detected, in a type-specific amplification reaction.
    Type: Application
    Filed: October 12, 2006
    Publication date: February 8, 2007
    Inventors: Brigitte Desiree Colau, Gary Dubin, Marie-Therese Martin, Wim Quint, Leen-Jan Van Doorn
  • Vaccine
    Publication number: 20070020288
    Abstract: This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV 16 and HPV 18 virus like particles provides cross-protection against other HPV types.
    Type: Application
    Filed: December 16, 2005
    Publication date: January 25, 2007
    Inventors: Gary Dubin, Bruce Innis, Moncef Slaoui, Martine Wettendorff
  • Hpv-16 and-18 l1 vlp vaccine
    Publication number: 20060251676
    Abstract: The invention relates to use of HPV 16 and HPV 18 VLPs to provide cross protection against infection and/or disease by other HPV types.
    Type: Application
    Filed: December 18, 2003
    Publication date: November 9, 2006
    Inventors: Gary Dubin, Bruce Innis, Moncef Slaoui, Martine Wettendorff
  • Vaccine
    Publication number: 20050287161
    Abstract: This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.
    Type: Application
    Filed: April 26, 2005
    Publication date: December 29, 2005
    Inventors: Gary Dubin, Bruce Innis, Moncef Slaoui, Martine Cecile Wettendorff
  • Assay
    Publication number: 20050037352
    Abstract: A process for identification of type-specific polynucleotide sequences in a sample, the process comprising the steps of (1) contacting polynucleotides from the sample, or derived from the sample, with a plurality of type-specific probes in the context of a solid support, and detection of any type-specific hybridisation; and (2) contacting polynucleotides in the sample, or derived from the sample, with type-specific primers for those types capable of being detected by the hybridisation step in step 1, but not so detected, in a type-specific amplification reaction.
    Type: Application
    Filed: August 6, 2002
    Publication date: February 17, 2005
    Inventors: Brigitte Colau, Gary Dubin, Marie-Therese Martin, Wim Quint, Leen-Jan Van Doorn
  • Soluble herpesvirus glycoprotein complex vaccine
    Publication number: 20030152583
    Abstract: The invention is directed to a herpes simplex virus vaccine comprising a herpes simplex virus glycoprotein H-glycoprotein L complex. The invention is also directed to a vaccine comprising a DNA encoding a herpes simplex virus glycoprotein H-glycoprotein L complex. Also included is an antibody which specifically binds to a herpes simplex virus glycoprotein H-glycoprotein L complex and DNA encoding the same.
    Type: Application
    Filed: February 20, 2003
    Publication date: August 14, 2003
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: Gary H. Cohen, Roselyn J. Eisenberg, Tao Peng, Gary Dubin
  • Soluble herpesvirus glycoprotein complex vaccine
    Patent number: 6541459
    Abstract: The invention is directed to a herpes simplex virus vaccine comprising a herpes simplex virus glycoprotein H-glycoprotein L complex. The invention is also directed to a vaccine comprising a DNA encoding a herpes simplex virus glycoprotein H-glycoprotein L complex. Also included is an antibody which specifically binds to a herpes simplex virus glycoprotein H-glycoprotein L complex and DNA encoding the same.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: April 1, 2003
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Gary H. Cohen, Roselyn J. Eisenberg, Tao Peng, Gary Dubin
  • Soluble herpesvirus glycoprotein complex vaccine
    Patent number: 6156319
    Abstract: The invention is directed to a herpes simplex virus vaccine comprising a herpes simplex virus glycoprotein H-glycoprotein L complex. The invention is also directed to a vaccine comprising a DNA encoding a herpes simplex virus glycoprotein H-glycoprotein L complex. Also included is an antibody which specifically binds to a herpes simplex virus glycoprotein H-glycoprotein L complex and DNA encoding the same.
    Type: Grant
    Filed: July 31, 1997
    Date of Patent: December 5, 2000
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Gary H. Cohen, Roselyn J. Eisenberg, Tao Peng, Gary Dubin
  • Soluble herpesvirus glycoprotein complex
    Patent number: 5807557
    Abstract: The invention features a preparation of a soluble herpesvirus gH/gL complex, a cell encoding a soluble herpesvirus gH/gL complex, a vaccine comprising the complex and a method of immunizing a human against a herpesvirus infection using the complex. The invention further features a method of identifying antiviral compounds using a soluble herpesvirus gH/gL complex.
    Type: Grant
    Filed: July 25, 1994
    Date of Patent: September 15, 1998
    Assignee: The Trustees of the University of Pennsylvania
    Inventor: Gary Dubin